- Long-Term Efficacy of Anti-Tumor Necrosis Factor Agents in Pediatric Luminal Crohn's Disease: A Systematic Review of Real-World Evidence Studies
-
van Rheenen H, van Rheenen PF
- KMID: 2471621
- Pediatr Gastroenterol Hepatol Nutr.
- 2020 Mar;23(2):121-131.
- doi: 10.5223/pghn.2020.23.2.121
PURPOSE: To determine the long-term efficacy of the anti-tumor necrosis factor (TNF) agents, infliximab (IFX) and adalimumab (ADA), in pediatric luminal Crohn's disease (CD) by performing a systematic literature review. METHODS:... -
- CITED
-
- Close
- SHARE
-
- Close
